Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation

BACKGROUND: In childhood cancer, consolidation treatment with chemotherapy followed by autologous hematopoietic progenitor stem cell transplantation is currently an accepted treatment modality in patients with high-risk solid tumors or in patients who have relapsed after conventional treatment. OBJE...

Descripción completa

Detalles Bibliográficos
Autores principales: Vargas, Alberto Olaya, Luna, Roberto Rivera, Garcia, Martin Perez, Cardos, Rocio Cárdenas, Hidalgo, Liliana Velasco, Jácome, Doris LordMéndez, Gutiérrez, Mariana Campos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Hematologia e Hemoterapia 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832315/
https://www.ncbi.nlm.nih.gov/pubmed/24255618
http://dx.doi.org/10.5581/1516-8484.20130099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832315/
https://www.ncbi.nlm.nih.gov/pubmed/24255618
http://dx.doi.org/10.5581/1516-8484.20130099

Ejemplares similares